Optometrists in Mokena, IL Accepting Medicare

5 Optometrists found. Showing 1 - 5

Jack G Guenther, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 19607 S Lagrange Road, Mokena, IL 60448 Phone: 708-479-1616    Fax: 708-479-6699

Absolute Vision Care Ii Ltd Optometrist Medicare: Medicare Enrolled Practice Location: 20006 Wolf Rd, Mokena, IL 60448 Phone: 708-478-1022    Fax: 708-930-1844

Jg Eyecare,ltd Optometrist Medicare: Medicare Enrolled Practice Location: 19607 La Grange Rd, Mokena, IL 60448 Phone: 708-479-1616    Fax: 708-479-6699

Dr. James B Sowinski, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 20006 Wolf Rd, Mokena, IL 60448 Phone: 708-478-1022    Fax: 708-930-1844

Dr. Alex Lopez, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 20006 Wolf Rd, Mokena, IL 60448 Phone: 708-478-1022

News Archive

Discovery brings embryonic stem cell medicine a step closer

A team of scientists announced a critical step on the path of realizing the promise of embryonic stem (ES) cells for medicine. The researchers have discovered unique molecular imprints coupled to DNA in mouse ES cells that help explain the cells' rare ability to form almost any body cell type. These imprints, or "signatures," appear near the master genes that control embryonic development and probably coordinate their activity in the early stages of cell differentiation. Not only do these findings help to unlock the basis for ES cells' seemingly unlimited potential, they also suggest ways to understand why ordinary cells are so limited in their abilities to repair or replace damaged cells.

Altarum Institute forms new center to focus on macro-economics of health spending

Altarum Institute President and CEO Lincoln Smith today announced the formation of the Altarum Institute Center for Studying Health Spending. The center will be a part of Altarum's internal Systems Research and Initiatives group and will focus on the macro-economics of health spending, health workforce, government outlays, and long-term fiscal sustainability.

Isis Pharmaceuticals awarded $1.5 million NIH grant to improve RNAi-based therapeutics

Isis Pharmaceuticals, Inc. has announced that it has been awarded a multi-year Phase 2 Small Business Innovation Research (SBIR) grant by the National Institutes of Health (NIH) for up to $1.5 million to design oligonucleotide drugs that can exploit the RNA interference (RNAi) antisense mechanism for disease treatment.

Kindred Healthcare consolidated revenues decline 1% to $1.22 billion in Q4 2013

Kindred Healthcare, Inc. today announced its operating results for the fourth quarter and year ended December 31, 2013. The Company continues to benefit from its repositioning strategy through the planned exit from a nursing center and a transitional care hospital and the closure of another nursing center during the fourth quarter of 2013.

Read more Medical News

› Verified 5 days ago